Department of nuclear medicine and positron emission tomography
Head of the Department
Sergienko V.B., Professor.
Department of nuclear medicine and positron emission tomography was established in 1984. Since that and to the present day, the department is advanced in staff qualification and technical equipment. Here, for the first time in Russian Federation, methods of radionuclide diagnostics were introduced, many new radiopharmaceuticals were developed. Now almost all nuclear methods known in world practice are performed in the department, both in cardiology and in related disciplines, an enormous clinical experience has been gained in the use of methods of radionuclide tomography. The department includes a laboratory of radioisotope diagnostics and a laboratory of biological and physicochemical analysis.
Over the years, the department has developed from the difficult implementation and improvement of the first techniques using radioactive isotopes to the routine usage of the full range of modern radionuclide tomographic methods. Specialists of high professional level work in the department, among them there is laureate of the Prize of the USSR Council of Ministers, 7 doctoral dissertations, more than 50 Ph.D. dissertations have been published. The scientific staff of the department participates in the annual European and World Congresses of Nuclear Medicine.
Methods of radionuclide tomography are the most important stage in the diagnosis of patients with various pathologies, including cardiology, neurology and oncology:
- myocardial perfusion SPECT at rest and stress-test is the main method for detecting transient myocardial ischemia, selecting patients for coronary artery disease for coronary angiography, evaluating the effectiveness of endovascular interventions. The method allowed to start new research directions in clinical cardiology on the pathogenesis of atherosclerosis, ischemic heart disease, the effect of treatment on perfusion and viability of the myocardium.
- bone scintigraphy allows visualization of bone metastases in cancer patients. When it is impossible to perform a PET study, bone scintigraphy is the key method for assessing the severity of the metastatic process and monitoring the effectiveness of chemotherapy and radiotherapy.
- pulmonary perfusion scintigraphy and SPECT is the main method of excluding pulmonary embolism and assessing the severity of pulmonary microcirculation in pulmonary hypertension of various origins.
- Thyroid scintigraphy is a method for identifying the functional autonomy of the thyroid nodes detected by ultrasound, as well as other causes of hyperthyroidism.
- parathyroid gland scintigraphy is a sensitive method for detecting thyroid hyperfunction, primarily adenomas
- 123I-MIBG scintigraphy is a method for detecting pheochromocytomas, and is also used to evaluate myocardial sympathetic innervation.
- Dynamic renal scintigraphy is a method for assessing the secretory and excretory functions of the kidneys in various pathologies, including renal artery stenosis, hypertension, and allows the most accurately estimation of glomerular filtration rate (GFR).
- scintigraphy and myocardial SPECT with pyrophosphate is a method for the diagnosis of acute focal myocardial damage.
The department is equipped with modern radio diagnostic tomography equipment:
- Single photon emission computed tomograph combined with a computed tomography scanner (SPECT/CT) Philips BrightView XCT
- Single-photon emission computer tomograph Philips Skylight
- Sergienko VB - Head of Department, Professor
- Ansheles AA – senior researcher, radiologist, D.Sc.
- Mironov SP- radiologist, professor
- Marchenkov NS - senior researcher, Ph.D.
- Vasilenko EI – head of laboratory of radioisotope diagnostics, Ph.D.
- Bugriy ME – head of PET laboratory
- Karalkina MA - radiologist, Ph.D.
- Chanakhchyan FN – cardiologist, radiologist, Ph.D.
- Cholak PM – radiologist
- Yastrebova AN - senior nurse
- Sidorova TN - Research Assistant
- Shpakova KE - research assistant
- Gulyakina EV - nurse
- Dvoryanchikov AV - technician